Andrew Anagnost Purchases Shares of HubSpot, Inc.
Andrew Anagnost acquired 1,211 shares of HubSpot, Inc. on June 16, 2026.
Key Points
- Andrew Anagnost bought 1,211 shares of HubSpot, Inc. on June 16, 2026, at $182.85 each.
- HubSpot, Inc. trades on the NYSE with a market cap of approximately $9.05 billion and a P/E ratio of 93.
- Major institutional investors like BlackRock and JPMorgan have also adjusted their positions in HubSpot recently.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Andrew Anagnost has purchased 1,211 shares of HubSpot, Inc. (NYSE:HUBS) as of June 16, 2026. The stock was trading at $182.85 at the time of this transaction.
Other Institutional Activity in HubSpot
Institutional investors have shown interest in HubSpot. BlackRock, Inc. increased its holdings by 262,272 shares, bringing its total to 4,098,507 shares valued at about $1.00 billion. JPMorgan Chase & Co. also grew its position by 389,346 shares, ending with 2,655,310 shares worth approximately $631.46 million. Meanwhile, Price T Rowe Associates Inc added 23,975 shares for a total of 4,605,897 shares valued at $1.12 billion.
HubSpot, Inc. Stock Down 32.2%
Shares of HubSpot, Inc. are currently trading near $182.85. The company has a market cap of approximately $9.05 billion and a P/E ratio of 93. Its forward P/E is 11.32, and the stock has a beta of 1.198. Over the past 52 weeks, the stock has ranged from a low of $173.25 to a high of $568.16. HubSpot's 50-day moving average is $211.57, while its 200-day moving average is $328.24.
$HUBS stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
HubSpot reported revenue of $3.30 billion, reflecting a growth rate of 23.4%. The company's net margin stands at 3.04%, with a return on equity of 5.01%. Its next earnings release is scheduled for August 5, 2026.
Insider Buying and Selling at HubSpot, Inc.
Several insiders, including Michael Berry, Jay Simons, Brian Halligan, Jill Ward, Claire D'Oyly-Hughes Johnson, and Lorrie Norrington, each bought 1,211 shares of HubSpot on June 16, 2026.
Analysts Set New Price Targets
On May 11, 2026, Barclays maintained its buy rating on HubSpot with a price target of $270. UBS also maintained a buy rating with a target of $250 on May 8, 2026. Meanwhile, Macquarie downgraded the stock to hold with a $190 target, and Citigroup set a hold rating with a $230 target.
About HubSpot, Inc.
HubSpot, Inc. offers a cloud-based CRM platform for businesses across the Americas, Europe, and the Asia Pacific. Its CRM includes tools for marketing automation, sales, service management, and content management. Headquartered in Cambridge, Massachusetts, HubSpot is led by CEO Yamini Rangan and employs over 9,000 people.
Bottom Line
Andrew Anagnost's purchase of HubSpot shares highlights ongoing interest in the company from both insiders and institutional investors. With a diverse CRM platform and a solid market presence, HubSpot continues to attract attention in the tech sector. As always, investors should remember that insider transactions are disclosed after the fact and may not reflect current positions.
Get HubSpot, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HUBS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.